ScholarIQanswers from OpenAlex

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

PaperCitations, authors & open-access status

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease have?

ScholarIQcitation count

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease has 103 citations in the OpenAlex counts ScholarIQ stores.

When was A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease published?

ScholarIQyear

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease has 2022 year in the ScholarIQ index.

What is the open-access status of A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease?

ScholarIQoa status

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease has gold oa status in the ScholarIQ index.

What is the DOI of A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease?

ScholarIQdoi

The DOI for A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease is on the source record.

What is the PMID of A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease?

ScholarIQpmid

The PMID for A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease is on the source record.

What is the OpenAlex record for A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease?

ScholarIQopenalex

The OpenAlex for A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial